(Q40754979)

English

Production of tumor necrosis factor alpha and interferon gamma in interleukin-2-treated melanoma patients: correlation with clinical toxicity

scientific article published on January 1991

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Production of tumor necrosis factor alpha and interferon gamma in interleukin-2-treated melanoma patients: correlation with clinical toxicity (English)

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

author name string

J S Economou

1

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

M Hoban

2

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

J D Lee

3

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

R Essner

4

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

S Swisher

5

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

W McBride

6

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

D B Hoon

7

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

D L Morton

8

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 January 1991

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Cancer Immunology, Immunotherapy

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

34

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

49-52

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

https://scigraph.springernature.com/pub.10.1007/bf01741324

0 references

Tumour necrosis factor production by IL-2-activated macrophages in vitro and in vivo

1 reference

https://pubmed.ncbi.nlm.nih.gov/1760811

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Suppressor cell activity in a randomized trial of patients receiving active specific immunotherapy with melanoma cell vaccine and low dosages of cyclophosphamide

1 reference

https://pubmed.ncbi.nlm.nih.gov/1760811

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Human tumor infiltrating lymphocytes. Analysis of lymphokine mRNA expression and relevance to cancer immunotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/1760811

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interleukin-2 initiates metabolic responses associated with critical illness in humans

1 reference

https://pubmed.ncbi.nlm.nih.gov/1760811

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunological reactivity and bioactivity of tumour necrosis factor

1 reference

https://pubmed.ncbi.nlm.nih.gov/1760811

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tumor necrosis factor in the pathophysiology of infection and sepsis

1 reference

https://pubmed.ncbi.nlm.nih.gov/1760811

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Endotoxin and tumor necrosis factor challenges in dogs simulate the cardiovascular profile of human septic shock

1 reference

https://pubmed.ncbi.nlm.nih.gov/1760811

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Successful therapy of natural killer-resistant pulmonary metastases by the synergism of gamma-interferon with tumor necrosis factor and interleukin-2 in mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/1760811

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Combination tumor-immunotherapy with recombinant tumor necrosis factor and recombinant interleukin 2 in mice.

1 reference

https://pubmed.ncbi.nlm.nih.gov/1760811

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Combination cytokine immunotherapy with tumor necrosis factor alpha, interleukin 2, and alpha-interferon and its synergistic antitumor effects in mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/1760811

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vivo induction of IL-6 by administration of exogenous cytokines and detection of de novo serum levels of IL-6 in tumor-bearing mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/1760811

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Influences of interleukins 2 and 4 on tumor necrosis factor production by murine mononuclear phagocytes.

1 reference

https://pubmed.ncbi.nlm.nih.gov/1760811

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cytokine gene expression during the generation of human lymphokine-activated killer cells: early induction of interleukin 1 beta by interleukin 2.

1 reference

https://pubmed.ncbi.nlm.nih.gov/1760811

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High-dose recombinant interleukin 2 in the treatment of patients with disseminated cancer. Responses, treatment-related morbidity, and histologic findings

1 reference

https://pubmed.ncbi.nlm.nih.gov/1760811

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical effects and toxicity of interleukin-2 in patients with cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/1760811

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Passive immunization against tumor necrosis factor partially abrogates interleukin 2 toxicity

1 reference

https://pubmed.ncbi.nlm.nih.gov/1760811

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Detection of circulating tumor necrosis factor after endotoxin administration.

1 reference

https://pubmed.ncbi.nlm.nih.gov/1760811

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/BF01741324

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40754979&oldid=1906705462"